selectively targeting Nrf2-activated pancreatic cancer by inhibiting asparagine synthesis pathway; induction of apoptosis in Nrf2-activated pancreatic cancer cells independent of ROS. This evidence concerns the gene NFE2L2 and pancreatic neoplasm.